Search

Begin New Search Topic Health Publishing Institution Council on Foreign Relations Publication Year within 10 Years

1. The Global Fund's China Legacy

Author:
Yanzhong Huang
Publication Date:
03-2014
Content Type:
Working Paper
Institution:
Council on Foreign Relations
Abstract:
The Global Fund to Fight AIDS, Tuberculosis and Malaria (hereafter "the Global Fund" or "the Fund") is the world's main multilateral funder in global health and the largest financier of anti-AIDS, anti-tuberculosis (TB), and anti-malaria programs. Since its inception in 2002, the Global Fund has disbursed $23.2 billion to more than 140 countries; today, it accounts for 21 percent of the international funding for the prevention and treatment of HIV/AIDS, 82 percent of that for TB, and 50 per cent of that for malaria. Until recently, it awarded grants based on the need of individual countries and the quality of each proposal. As a performance-based initiative, it closely tracks the results flowing from each grant disbursement. As a value-oriented organization, it requires recipients to have transparent, accountable, and inclusive governance mechanisms. Indeed, in terms of multisectoralism and civil society participation, the Fund is considered the most progressive global health institution. But unlike many other health-related multilateral organizations, it is not an implementing agency and lacks in-country presence. Instead, as a funding mechanism, it has grant applications and project/program implementation in each country overseen by a "country coordinating mechanism" (CCM), which draws representatives from government, UN and donor agencies, nongovernmental organizations (NGOs), the private sector, and people living with the diseases.
Topic:
Civil Society, Economics, Health, and Governance
Political Geography:
China and East Asia

2. Designing a Global Coalition of Medicines Regulators

Author:
Stewart M. Patrick and Jeffrey Wright
Publication Date:
08-2014
Content Type:
Policy Brief
Institution:
Council on Foreign Relations
Abstract:
Globalization has transformed the marketplace for medicines in recent decades, giving rise to new threats including the poor traceability of global supply chains, counterfeit and substandard medicines, and antibacterial resistance. Aware that public drug authorities must cooperate to meet the emerging challenges of modern medicines regulation, the U.S. Food and Drug Administration (FDA) has been discussing with counterpart agencies abroad creating a"global coalition of regulators." Yet a coalition alone is not enough; the devil, as always, will be in the details. In pursuit of this goal, the FDA and partner medicines regulatory agencies should design a coalition with five distinct features: narrow scope, to promote realistic goals; flexibility, to adapt to future circumstances; selective membership, to maximize like mindedness, particularly in the early stages; nongovernmental (NGO) participation, to leverage the capacities of both NGOs and for-profit corporations; and institutional partnerships, to orchestrate the activities of other regulatory organizations.
Topic:
Globalization, Health, International Cooperation, and Non-Governmental Organization

3. The Emerging Global Health Crisis

Author:
Mitchell E. Daniels Jr., Thomas E. Donilon, and Thomas J. Bollyky
Publication Date:
12-2014
Content Type:
Special Report
Institution:
Council on Foreign Relations
Abstract:
Rates of heart disease, cancer, diabetes, and other noncommunicable diseases (NCDs) in low- and middle-income countries are increasing faster, in younger people, and with worse outcomes than in wealthier countries. In 2013 alone, NCDs killed eight million people before their sixtieth birthdays in developing countries. A new CFR-sponsored Independent Task Force report and accompanying interactive look at the factors behind this epidemic and the ways the United States can best fight it. NCDs will affect U.S. interests because of their human, economic, and strategic consequences. "More patients will get sick, suffer longer, require more medical care, and die young. Given the scale of these trends, the results will reverberate," the Task Force warns. It is projected that the NCD epidemic will inflict $21.3 trillion in losses in developing countries over the next two decades—a cost nearly equal to the entire economic output of those countries in 2013. "These economic consequences will undercut potential U.S. trade partners and allies and may reduce domestic support for governments of U.S. strategic interest." The Task Force says the United States and like-minded partners can help developing countries meet the NCD challenge at relatively modest cost and "slow the rise of this epidemic, lessen its worst effects, and help provide national governments with the time and technical assistance needed to tackle this emerging crisis sustainably on their own." The U.S. government should take two immediate steps, the Task Force says: examine its global health priorities and spending and ensure their continued effectiveness; and convene governments and other potential partners from around the world to develop a plan for collective action on NCDs in low- and middle-income countries. The Task Force encourages the United States to focus on the NCDs and risk factors most prevalent among the working-age poor in developing countries. Low-cost interventions are available and should be integrated into existing U.S. global health efforts. Based on these criteria, the Task Force maintains that: In the short term U.S. leadership would have a significant effect on cardiovascular disease, tobacco control, liver cancer, and cervical cancer. "Low-cost, prevention-based solutions exist for each challenge and the United States is in the position to help local governments implement them." More on: Noncommunicable Diseases Global Public Health Threats and Pandemics In the medium term U.S. leadership would make a tremendous difference to address diabetes and treatable and curable cancers, such as leukemia and breast cancer. "The Task Force has identified several NCD challenges for which effective interventions are widely used in the United States and other high-income countries, but not yet sufficiently low cost or usable in low-infrastructure settings . . .With U.S. leadership, more population and implementation research, and collaboration with private sector and philanthropic partners, progress on adapting these interventions for cost-effective, low-infrastructure use is foreseeable in the near term." U.S. collaboration with developing countries and the private sector may help ameliorate poor diets and nutrition, physical inactivity, and obesity. It could also help integrate mental health into primary care and provide low-cost chronic care programs and technologies.
Topic:
Health, International Cooperation, Governance, and Health Crisis
Political Geography:
North America and United States of America